Bharat Immunologicals Financial Statements Trends

This module enables investors to look at Bharat Immunologicals various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as , but also many exotic indicators such as . This module is a perfect complement to use when analyzing Bharat Immunologicals Valuation or Volatility. It can also complement various Bharat Immunologicals Technical models. Check also analysis of Bharat Immunologicals Correlation with competitors.

Price to Sales Analysis

Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Bharat Immunologicals 
P/S 
 = 
MV Per Share 
Revenue Per Share 
 = 
0.66 times

About Price to Sales

The most important factor to remember is that the price of equity takes a firm's debt into account, whereas the sales does not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
Compare to competition
Based on latest financial disclosure the price to sales indicator of Bharat Immunologicals Biologicals Corp Ltd is roughly 0.66 times. This is much higher than that of the sector, and significantly higher than that of Price to Sales industry, The Price to Sales for all stocks is over 1000% lower than the firm.

Bharat Immunologicals Fundamental Drivers Relationships

Bharat Immunologicals Biologicals Corp Ltd is rated below average in price to sales category among related companies. It is rated below average in market capitalization category among related companies creating about  1,757,575,758  of Market Capitalization per Price to Sales.

Peer Comparison

Bharat Immunologicals Earnings Per Share Comparison
Bharat Immunologicals is currently under evaluation in earnings per share category among related companies.

Did you try this?

Run Portfolio Backtesting Now
   

Portfolio Backtesting

Avoid under-diversification and over-optimization by backtesting your portfolios
Hide  View All  Next  Launch Portfolio Backtesting

Fundamental Indicators

Current Bharat Immunologicals financial ratios